CVS Caremark to cover Zepbound again after lawsuit, widespread backlash

CVS Caremark is adding Zepbound, Eli Lilly’s obesity drug, back to its commercial insurance plan formularies, more than a year after it stopped covering it in favor of Novo Nordisk’s Wegovy.

Vanessa Trump reveals breast cancer diagnosis

Vanessa Trump revealed Wednesday that she has been diagnosed with breast cancer and has started a treatment plan.

California’s $1.3B Medicaid funding put on hold amid fraud suspicions

The Trump administration is widening its initiative to eliminate fraud in the federal health program, which includes a $1.3 billion deferral of Medicaid funding to California.

Amazon stocking Ozempic pills at kiosks, offering same-day delivery

Amazon is making Ozempic pills more accessible and stocking its U.S. kiosks with the medication and offering same-day delivery.

White House says Trump's drugmaker deals could save economy $529B over next decade

President Trump’s “most favored nation” drugmaker deals could save the economy $529 billion over the next decade, a new White House analysis estimates.

Supreme Court restores abortion pill access

The Supreme Court has restored broad access to the abortion pill mifepristone.

Trump says GLP-1 weight-loss drugs coming at $50 for Medicare patients

President Trump announced the popular GLP-1 weight loss drugs would soon be more accessible to millions of Americans at a cost of only $50 per month.

AI shaping our health care decisions, even whether we go to the doctor

For nearly half of Americans, artificial intelligence plays some sort of role in their health care decisions, a new Gallup poll found. 

Fundraiser aims to expand dental care for southeast Wisconsin kids

Community Smiles Dental says 100,000 local kids need care as its Laugh for a Smile fundraiser and silent auction aim to expand services for Medicaid and uninsured families.

FDA approves Foundayo, Eli Lilly's new GLP-1 obesity pill

The U.S. Food and Drug Administration has approved Eli Lilly’s new weight-loss GLP-1 pill, orforglipron, which will be sold as Foundayo.

Annual CDC mobile lung screenings for coal miners begins in April across several states See where

The annual Centers for Disease Control (CDC) ​​National Institute for Occupational Safety and Health (NIOSH) black lung screenings for coal miners will start in April across several states.